Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has announcements × Biliary Tract Neoplasms × durvalumab × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Small Cell Lung Carcinoma 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Urinary Bladder Neoplasms 1 Ovarian Neoplasms 1 Non Small Cell Lung Cancer NSCLC 1 Lung Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Hepatocellular 1 Biliary Tract Neoplasms 1

Interventions

trametinib 1 pembrolizumab 1 larotrectinib 1 durvalumab 1 dabrafenib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03875235 2026-02-27

TOPAZ-1

AstraZeneca

Phase 3 Active not recruiting

810 enrolled 24 charts 1 FDA

Gastrointestinal

Biliary Tract Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡